StockWatch
·
Pharmaceuticals
Quarterly Result5 Nov 2026, 01:05 pm

Fermenta Biotech declares Q2 FY27 Unaudited Financial Results

AI Summary

Fermenta Biotech Limited announced the approval of its Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. The Board of Directors met on November 05, 2026, to approve these results. The company also received Limited Review Reports from its statutory auditors, M/s. SRBC & Co. LLP, with an unmodified opinion. The board meeting commenced at 12:00 p.m. IST and concluded at 12:39 p.m. IST.

Key Highlights

  • Board approved unaudited financial results for Q2 FY27.
  • Results were declared on a standalone and consolidated basis.
  • Limited Review Reports received from auditors.
  • Auditors provided an unmodified opinion on the results.
  • Board meeting concluded within an hour.